-
1
المؤلفون: Paiva, Bruno, Mateos, María Victoria, Sanchez-Abarca, Luis Ignacio, Puig, Noemi, Vidriales, María-Belén, López-Corral, Lucía, Corchete, Luis A, Hernandez, Miguel T, Bargay, Joan, de Arriba, Felipe, de la Rubia, Javier, Teruel, Ana-Isabel, Giraldo, Pilar, Rosiñol, Laura, Prosper, Felipe, Oriol, Albert, Hernández, José, Esteves, Graça, Lahuerta, Juan José, Bladé, Joan, Perez-Simon, Jose Antonio, San Miguel, Jesús F, Spanish Myeloma Group / Program Study and Treatment of Hematological Malignancies cooperative study groups
المساهمون: Instituto de Salud Carlos III, Asociación Española Contra el Cáncer, European Research Council, Red Temática de Investigación Cooperativa en Cáncer (España)
المصدر: Digital.CSIC. Repositorio Institucional del CSIC
instname
Blood
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
Dadun. Depósito Académico Digital de la Universidad de Navarraمصطلحات موضوعية: Adult, Male, medicine.medical_treatment, T-Lymphocytes, Immunology, Biochemistry, Dexamethasone, Immunophenotyping, Maintenance Chemotherapy, 03 medical and health sciences, 0302 clinical medicine, Immune system, Aldesleukin, Risk Factors, hemic and lymphatic diseases, Biomarkers, Tumor, Medicine, Humans, IL-2 receptor, Longitudinal Studies, Lenalidomide, Multiple myeloma, Aged, Cell Proliferation, Demography, Aged, 80 and over, business.industry, Cell Biology, Hematology, Immunotherapy, Induction Chemotherapy, Middle Aged, medicine.disease, Thalidomide, Immunosurveillance, Killer Cells, Natural, body regions, 030220 oncology & carcinogenesis, Female, Ciencias de la Salud::Hematología [Materias Investigacion], business, Multiple Myeloma, CD8, 030215 immunology, medicine.drug
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a00af9d674b2dda137189561ec4bbb03Test
https://hdl.handle.net/10171/52183Test -
2
المؤلفون: Anne Banos, Michel Attal, Salomon Manier, Christine Chen, Jin Lu, Javier de la Rubia, Andrew Belch, Michele Cavo, Angela Dispenzieri, Mourad Tiab, John Catalano, Guang Chen, Lugui Qiu, Aurore Perrot, Je-Jung Lee, Katja Weisel, Hervé Avet-Loiseau, Vanessa Houck, Philippe Moreau, Murielle Roussel, Thierry Facon, Nizar J. Bahlis, Heinz Ludwig, Kenneth C. Anderson, Antonello Pinto, Catarina Geraldes, Xavier Leleu, Bertrand Arnulf, Annette Ervin-Haynes, Albert Oriol, Lotfi Benboubker, Meletios A. Dimopoulos, Daniel Binder, Eileen M Boyle, Cyrille Hulin, Darrell White, Jamie D. Cavenagh, Michel Delforge, Mohamad Mohty
المساهمون: Facon, Thierry, Dimopoulos, Meletios A, Dispenzieri, Angela, Catalano, John V, Belch, Andrew, Cavo, Michele, Pinto, Antonello, Weisel, Katja, Ludwig, Heinz, Bahlis, Nizar J, Banos, Anne, Tiab, Mourad, Delforge, Michel, Cavenagh, Jamie D, Geraldes, Catarina, Lee, Je-Jung, Chen, Christine, Oriol, Albert, De La Rubia, Javier, White, Darell, Binder, Daniel, Jin, Lu, Anderson, Kenneth C, Moreau, Philippe, Attal, Michel, Perrot, Aurore, Arnulf, Bertrand, Qiu, Lugui, Roussel, Murielle, Boyle, Eileen, Manier, Salomon, Mohty, Mohamad, Avet-Loiseau, Herve, Leleu, Xavier, Ervin-Haynes, Annette, Chen, Guang, Houck, Vanessa, Benboubker, Lotfi, Hulin, Cyrille
المصدر: BLOOD
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Blood
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujolمصطلحات موضوعية: Melphalan, medicine.medical_specialty, Clinical Trials and Observations, Immunology, Urology, Antineoplastic Agents, Biochemistry, 03 medical and health sciences, 0302 clinical medicine, newly diagnosed multiple myeloma, medicine, Clinical endpoint, Humans, Progression-free survival, Survival analysis, Lenalidomide, business.industry, Hazard ratio, Cell Biology, Hematology, Survival Analysis, Progression-Free Survival, Surgery, Thalidomide, Transplantation, Treatment Outcome, 030220 oncology & carcinogenesis, Multiple Myeloma, business, 030215 immunology, medicine.drug
وصف الملف: ELETTRONICO
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e45bdb9fa36b02c60169dd625982ca3Test
https://doi.org/10.1182/blood-2017-07-795047Test -
3دورية أكاديمية
المؤلفون: Rosiñol, Laura1, Oriol, Albert2, Teruel, Ana Isabel3, Hernández, Dolores4, López-Jiménez, Javier5, de la Rubia, Javier6, Granell, Miquel7, Besalduch, Joan8, Palomera, Luis9, González, Yolanda10, Etxebeste, Ma Asunción11, Díaz-Mediavilla, Joaquín12, Hernández, Miguel T.13, de Arriba, Felipe14, Gutiérrez, Norma C.15, Martín-Ramos, Ma Luisa16, Cibeira, Ma Teresa1, Mateos, Ma Victoria15, Martínez, Joaquín16, Alegre, Adrián17
المصدر: Blood. 8/23/2012, Vol. 120 Issue 8, p1589-1596. 8p.
مصطلحات موضوعية: *THALIDOMIDE, *DEXAMETHASONE, *MULTIPLE myeloma treatment, *PROTEASOME inhibitors, *STEM cell transplantation, *RANDOMIZED controlled trials, *MEDICAL statistics